Kyverna Therapeutics, Inc. - Common Stock, par value $0.00001 per share (KYTX)
CUSIP: 501976104
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Stock, par value $0.00001 per share
- Shares outstanding
- 56,833,213
- Total 13F shares
- 28,136,737
- Share change
- -3,891,297
- Total reported value
- $138,294,516
- Put/Call ratio
- 986%
- Price per share
- $4.89
- Number of holders
- 92
- Value change
- -$28,965,516
- Number of buys
- 48
- Number of sells
- 43
Quarterly Holders Quick Answers
What is CUSIP 501976104?
CUSIP 501976104 identifies KYTX - Kyverna Therapeutics, Inc. - Common Stock, par value $0.00001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 501976104:
Top shareholders of KYTX - Kyverna Therapeutics, Inc. - Common Stock, par value $0.00001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Vida Ventures Advisors, LLC |
13F
|
Company |
8%
|
4,523,924
|
$33,929,430 | — | 30 Jun 2024 | |
| Bain Capital Life Sciences Investors, LLC |
13F
3/4/5
|
Company · 10%+ Owner |
5.9%
|
3,368,370
|
$25,262,775 | — | 30 Jun 2024 | |
| Northpond Ventures, LLC |
13F
|
Company |
5.7%
|
3,255,426
|
$24,415,695 | — | 30 Jun 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
3.6%
|
2,061,257
|
$15,459,428 | — | 30 Jun 2024 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
3.5%
|
1,983,000
|
$14,872,500 | — | 30 Jun 2024 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
3.3%
|
1,852,711
|
$13,895,333 | — | 30 Jun 2024 | |
| Novo Holdings A/S |
13F
|
Company |
3.1%
|
1,750,000
|
$13,125,000 | — | 30 Jun 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2.6%
|
1,453,667
|
$10,902,504 | — | 30 Jun 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.8%
|
1,016,621
|
$7,624,658 | — | 30 Jun 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.6%
|
923,082
|
$6,923,115 | — | 30 Jun 2024 | |
| Insight Holdings Group, LLC |
13F
|
Company |
1.6%
|
912,915
|
$6,846,863 | — | 30 Jun 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.4%
|
823,039
|
$6,172,793 | — | 30 Jun 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
1.3%
|
713,400
|
$5,350,500 | — | 30 Jun 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.2%
|
669,557
|
$5,022,000 | — | 30 Jun 2024 | |
| Casdin Capital, LLC |
13F
|
Company |
1%
|
575,000
|
$4,312,500 | — | 30 Jun 2024 | |
| GREAT POINT PARTNERS LLC |
13F
|
Company |
0.88%
|
499,152
|
$3,743,640 | — | 30 Jun 2024 | |
| EcoR1 Capital, LLC |
13F
|
Company |
0.79%
|
450,000
|
$3,375,000 | — | 30 Jun 2024 | |
| MBB PUBLIC MARKETS I LLC |
13F
|
Company |
0.72%
|
410,191
|
$3,076,433 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.66%
|
372,598
|
$2,794,923 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.56%
|
315,948
|
$2,369,610 | — | 30 Jun 2024 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.42%
|
236,029
|
$1,770,218 | — | 30 Jun 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.4%
|
228,137
|
$1,711,028 | — | 30 Jun 2024 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
0.35%
|
200,000
|
$1,500,000 | — | 30 Jun 2024 | |
| Artal Group S.A. |
13F
|
Company |
0.35%
|
200,000
|
$1,500,000 | — | 30 Jun 2024 | |
| E Fund Management Co., Ltd. |
13F
|
Company |
0.33%
|
189,432
|
$1,420,740 | — | 30 Jun 2024 | |
| NORGES BANK |
13F
|
Company |
0.32%
|
180,593
|
$1,354,448 | — | 30 Jun 2024 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.31%
|
178,963
|
$1,342,223 | — | 30 Jun 2024 | |
| Walleye Capital LLC |
13F
|
Company |
0.28%
|
156,515
|
$1,173,863 | — | 30 Jun 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.28%
|
156,296
|
$1,172,220 | — | 30 Jun 2024 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.26%
|
150,000
|
$1,125,000 | — | 30 Jun 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.23%
|
132,900
|
$996,750 | — | 30 Jun 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.22%
|
125,077
|
$938,078 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.21%
|
119,283
|
$894,623 | — | 30 Jun 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.21%
|
117,991
|
$884,932 | — | 30 Jun 2024 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.2%
|
115,365
|
$865,238 | — | 30 Jun 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.2%
|
112,709
|
$845,318 | — | 30 Jun 2024 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.16%
|
90,242
|
$676,815 | — | 30 Jun 2024 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.16%
|
90,000
|
$675,000 | — | 30 Jun 2024 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.15%
|
86,115
|
$645,863 | — | 30 Jun 2024 | |
| XTX Topco Ltd |
13F
|
Company |
0.15%
|
83,286
|
$624,645 | — | 30 Jun 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.13%
|
75,000
|
$562,500 | — | 30 Jun 2024 | |
| Jump Financial, LLC |
13F
|
Company |
0.12%
|
66,960
|
$502,201 | — | 30 Jun 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.11%
|
62,290
|
$467,175 | — | 30 Jun 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.11%
|
61,303
|
$459,772 | — | 30 Jun 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.1%
|
57,749
|
$433,119 | — | 30 Jun 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.1%
|
55,790
|
$418,426 | — | 30 Jun 2024 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
0.08%
|
47,850
|
$358,875 | — | 30 Jun 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.07%
|
42,424
|
$318,180 | — | 30 Jun 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.07%
|
40,490
|
$303,675 | — | 30 Jun 2024 | |
| Ghisallo Capital Management LLC |
13F
|
Company |
0.07%
|
40,000
|
$300,000 | — | 30 Jun 2024 |
Institutional Holders of Kyverna Therapeutics, Inc. - Common Stock, par value $0.00001 per share (KYTX) as of Q3 2024
As of 30 Sep 2024,
Kyverna Therapeutics, Inc. - Common Stock, par value $0.00001 per share (KYTX) was held by
92 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
28,136,737 shares.
The largest 10 holders included
Vida Ventures Advisors, LLC, Bain Capital Life Sciences Investors, LLC, Northpond Ventures, LLC, JPMORGAN CHASE & CO, Novo Holdings A/S, BlackRock, Inc., MILLENNIUM MANAGEMENT LLC, VANGUARD GROUP INC, FRANKLIN RESOURCES INC, and DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C).
This page lists
92
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
87
Q3 2024 holders
92
Holder diff
5
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.